Section of Oncology/Hematology (BC, QT, MA), Mary Babb Randolph Cancer Center Section of Hematology, West Virginia University, Morgantown, West Virginia; Department of Medicine (RT), West Virginia University, Morgantown, West Virginia; Section of Radiology, Hillman Cancer Center (AC), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and Department of Statistics (MC, YH), West Virginia University, Morgantown, West Virginia.
Am J Med Sci. 2014 Sep;348(3):262-4. doi: 10.1097/MAJ.0000000000000227.
Hematologists/Oncologists spend years of training in a fellowship program. At academic centers, patients receiving treatment are often seen by fellows. It has not been established what patients understand about fellowship training, therefore the purpose of this study was to explore their understanding and whether they are content with fellows taking part in their care.
At West Virginia University/Mary Babb Randolph Cancer Center, the authors drafted a survey. This anonymous and voluntary survey abstracted basic patient demographic data and experience being cared for by fellows and basic knowledge of a Hematology/Oncology fellowship. Multiple-choice questions were drafted with 4 to 6 answer choices with no option for unknown. Surveys were collected over a 3-week period in July 2012. Patients were surveyed at outpatient appointments, infusion center visits, and laboratory draws.
Two hundred twenty-six surveys were collected. Statistical analysis was performed and a binomial regression was fit to the data. There is evidence that higher levels of education are more likely to give correct answers (P = 0.035). Patients who stated that they had not seen a fellow or were unsure whether they had seen a fellow were more likely to select incorrect answers (P = 0.001). There is no statistical significance differentiating between cancer types in likelihood of getting answers correct. Of those surveyed, 1.77% felt that they completely understand the role of a fellow in their care, whereas 80.45% desired further information about fellows. Only 2.2% disliked having a fellow involved in their care.
Patients at academic centers being seen by Hematology/Oncology fellows appear to have a lack of knowledge of a fellow's role and background but have a desire to be educated. Educational initiatives can be introduced to teaching institutions to help patients better understand the role of a fellow.
血液科/肿瘤科医生需要经过多年的专业培训才能成为一名研究员。在学术中心,接受治疗的患者通常由研究员进行诊治。目前尚不清楚患者对研究员培训的了解程度,因此,本研究的目的是探讨他们的理解程度,以及他们是否满意研究员参与他们的治疗。
在西弗吉尼亚大学/玛丽·巴巴·兰道夫癌症中心,作者起草了一份调查。这份匿名且自愿的调查摘要了患者的基本人口统计学数据和接受研究员治疗的经验,以及对血液科/肿瘤科研究员培训的基本了解。多项选择题有 4 到 6 个答案选项,没有未知选项。调查在 2012 年 7 月的 3 周内收集。患者在门诊预约、输液中心就诊和实验室采血时接受调查。
共收集了 226 份调查。进行了统计分析,并对数据进行了二项式回归分析。有证据表明,教育水平越高,答对的可能性越大(P=0.035)。表示未见过研究员或不确定是否见过研究员的患者更有可能选择错误答案(P=0.001)。不同癌症类型的患者答对的可能性没有统计学差异。在接受调查的患者中,1.77%的人认为他们完全理解研究员在他们治疗中的角色,而 80.45%的人希望进一步了解研究员。只有 2.2%的人不喜欢有研究员参与他们的治疗。
在学术中心接受血液科/肿瘤科研究员诊治的患者似乎对研究员的角色和背景缺乏了解,但他们有接受教育的愿望。可以在教学机构引入教育计划,帮助患者更好地理解研究员的角色。